NAFLD presence also significantly increases HUA risk (17, 21) due to the increased xanthine oxidase (XO) expression or activity in NAFLD patients, which catalyzes uric acid production (17). This evidence concerns the gene XDH and metabolic dysfunction-associated steatotic liver disease.